• Issue

    Journal of Pediatric Gastroenterology and Nutrition: Volume 78, Issue 1

    i-iii, 1-167
    January 2024

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: i-iii
  • First Published: 30 January 2024

On the Cover: “Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease” Kalveram et al 27–35

ORIGINAL ARTICLES

Gastroenterology: Inflammatory Bowel Disease

Open Access

Effectiveness of strategies to suppress antibodies to infliximab in pediatric inflammatory bowel disease

  • Pages: 57-67
  • First Published: 05 December 2023
Effectiveness of strategies to suppress antibodies to infliximab in pediatric inflammatory bowel disease

The development of antibodies to infliximab (ATIs) commonly causes a loss of response in children with inflammatory bowel disease. This retrospective cohort study showed that treatment escalation with infliximab (dose optimization and/or adding an immunomodulator) seems to be an effective strategy to suppress ATIs in patients with low ATI titers (≤30 AU/mL). For high ATI titers, this strategy could also be considered before switching.

Gastroenterology: Celiac Disease

Health-related quality of life in children with coeliac disease and in their families: A long-term follow-up study

  • Pages: 105-112
  • First Published: 11 December 2023
Health-related quality of life in children with coeliac disease and in their families: A long-term follow-up study

The health-related quality of life in children with coeliac disease and their parents did not differ after 10 years from diagnosis.